Clinical development of temsirolimus, a novel mTOR inhibitor, for treatment of advanced malignancies

Semin Oncol. 2009 Dec:36 Suppl 3:S1-2. doi: 10.1053/j.seminoncol.2009.10.014.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic / methods*
  • Clinical Trials as Topic / trends
  • Disease Progression
  • Humans
  • Neoplasms / drug therapy*
  • Protein Kinases* / metabolism
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use
  • TOR Serine-Threonine Kinases

Substances

  • Antineoplastic Agents
  • temsirolimus
  • Protein Kinases
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus